PEGINTERFERON BETA-1A for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 390 adverse event reports in the FDA FAERS database where PEGINTERFERON BETA-1A was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for PEGINTERFERON BETA-1A
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Influenza like illness | 1,431 | 11.5% | 2 | 174 |
| Injection site erythema | 1,041 | 8.4% | 0 | 119 |
| Multiple sclerosis relapse | 945 | 7.6% | 2 | 578 |
| Fatigue | 673 | 5.4% | 2 | 142 |
| Headache | 587 | 4.7% | 0 | 105 |
| Pain | 580 | 4.7% | 2 | 111 |
| Injection site reaction | 569 | 4.6% | 1 | 51 |
| Device malfunction | 567 | 4.6% | 0 | 9 |
| Multiple sclerosis | 536 | 4.3% | 14 | 153 |
| Pyrexia | 503 | 4.0% | 4 | 135 |
| Memory impairment | 455 | 3.7% | 1 | 45 |
| Malaise | 448 | 3.6% | 3 | 101 |
| Injection site pain | 435 | 3.5% | 0 | 35 |
| Fall | 406 | 3.3% | 5 | 214 |
| Drug dose omission | 389 | 3.1% | 0 | 12 |
Other Indications for PEGINTERFERON BETA-1A
Multiple sclerosis (11,105)
Product used for unknown indication (817)
Maternal exposure timing unspecified (82)
Secondary progressive multiple sclerosis (11)
Demyelination (7)
Relapsing multiple sclerosis (6)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)